Neuraptive Therapeutics
PA - ChesterbrookBiotechnology
Focus: Neuraptive Therapeutics is a biotech company focused on developing therapies for nerve repair and peripheral nerve injuries. Founded in 2016 and headquartered in Chesterbrook, PA, the company operates as a public-stage entity with a specialized focus on regenerative neurology.
Profile data last refreshed 20h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Total Funding
$11.5M
Open Jobs
0
About Neuraptive Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Neuraptive Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Clinical Trials (1)
NCT05565846NTX-001 to Repair Peripheral Nerve Transection(s)
N/AHelp build intelligence for Neuraptive Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.